Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Symptomatic glucocorticoid-induced adrenal suppression in the United Kingdom and Ireland: A BPSU study

Lookup NU author(s): Dr Claire WoodORCiD, Dr Laura Lane, Professor Mark PearceORCiD, Professor Timothy CheethamORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© Author(s) (or their employer(s)) 2024. Objective: To determine the incidence and describe the presentation and management of unexpected symptomatic glucocorticoid-induced adrenal suppression (AS) in children and young people aged 0-15 years. Setting and design: Surveillance study of symptomatic glucocorticoid (GC)-induced AS with supportive biochemical evidence or presenting as an adrenal crisis, reported via the British Paediatric Surveillance Unit (BPSU) from September 2020 to September 2022. Results: Over a 25-month period, 190 reports of symptomatic GC-induced AS/adrenal crisis were made, of which 22 were confirmed cases: 18 AS and 4 adrenal crises. This translates to an incidence rate of 0.09 new cases of GC-induced AS per 100 000 children aged 0-15 per year in the UK. There was a broad range of underlying diagnoses requiring GC prescription (16) and GC preparations (13). Of the 22 patients, 7 had more than 1 type of GC prescribed. The administration of oral GC occurred in 19 of the cases, inhaled GC use in 7, topical use in 5 and 1 case occurred after a single intramuscular injection of GC. All patients were discussed with a paediatric endocrinology team. Conclusions: The incidence of AS from this UK-based BPSU study is lower than a similar Canadian study. This may indicate that paediatricians in the UK and Ireland are becoming more aware of the potential for GC-induced AS and thus are more proactive to prevent its occurrence. The clinical cases still highlight the need to educate families and healthcare professionals with a view to further reducing the morbidity and potential mortality associated with GC-induced AS.


Publication metadata

Author(s): Wood CL, Lane LC, Barlow H, Drake AJ, Kanthagnany S-K, Pearce MS, Sachdev P, Blair JC, Cheetham T

Publication type: Article

Publication status: Published

Journal: Archives of Disease in Childhood

Year: 2025

Volume: 110

Issue: 5

Pages: 363-368

Print publication date: 01/05/2025

Online publication date: 21/12/2024

Acceptance date: 19/10/2024

Date deposited: 13/10/2025

ISSN (print): 0003-9888

ISSN (electronic): 1468-2044

Publisher: BMJ Publishing Group

URL: https://doi.org/10.1136/archdischild-2024-327510

DOI: 10.1136/archdischild-2024-327510

ePrints DOI: 10.57711/s5wa-1p82

Data Access Statement: Data are available upon reasonable request.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
JRE Scientific Committee
NIHR

Share